Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.
Christoph SchliemannTorsten KesslerAndrew F BerdelTeresa HemmerleLinus AngenendtBianca AltvaterClaudia RossigJan-Henrik MikeschGeorg LenzMichael SchäfersDario NeriMatthias StelljesWolfgang E BerdelPublished in: British journal of haematology (2021)